A systematic review of neuropsychiatric symptoms in mild cognitive impairment

Roberto Monastero1, Francesca Mangialasche, Cecilia Camarda

  • 1Section of Neurology, Department of Clinical Neuroscience, Laboratory of Epidemiology and Psychology of Aging and Dementia, University of Palermo, Palermo, Italy. roberto.monastero@unipa.it

Insights

Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment (MCI), affecting 35-85% of individuals. These symptoms, like depression, may predict progression to Alzheimer's disease.

Area of Science:

  • Neurology
  • Geriatrics
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) represents an intermediate stage between normal aging and dementia.
  • MCI is characterized by heterogeneity in clinical presentation, etiology, and prognosis.
  • Neuropsychiatric symptoms (NPS) are increasingly recognized in MCI populations.

Purpose of the Study:

  • To systematically review the prevalence and features of NPS in individuals with MCI.
  • To explore the potential role of NPS as risk factors or predictors for MCI progression.

Main Methods:

  • Systematic literature search of the PubMed database up to August 31, 2008.
  • Inclusion of articles with strict selection criteria and duplicate outcome variable extraction.
  • Analysis of 27 included articles, with 14 utilizing prospective cohorts.

Main Results:

  • Global prevalence of NPS in MCI ranged widely from 35% to 85%.
  • Depression, anxiety, and irritability were the most frequently observed behavioral symptoms.
  • Hospital-based studies reported higher NPS prevalence than population-based studies, likely due to methodological differences.

Conclusions:

  • NPS are highly prevalent in MCI, mirroring patterns seen in dementia and Alzheimer's disease (AD).
  • NPS, particularly depression, may serve as risk factors for MCI or predictors of conversion to AD.
  • Further large cohort studies with standardized criteria are needed to clarify the prognostic significance of NPS in MCI.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...